Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationships.
This laboratory has developed a flow cytometric approach for scoring in vitro micronuclei (In Vitro MicroFlow(®)) whose characteristics are expected to benefit studies designed to comprehensively investigate genotoxicity dose-response relationships. In particular, new experimental designs become possible when automated scoring is combined with treatment, processing and sampling that all occur in microtiter plates. To test this premise, experiments described herein investigated micronucleus (MN) formation in TK6 cells treated with genotoxic agents applied at 22 closely spaced concentrations in quadruplicate, with 10,000 cells analyzed per replicate. The genotoxicants colchicine, vinblastine sulfate, ethyl methanesulfonate, methyl methanesulfonate, ethyl nitrosourea, methyl nitrosourea, and bleomycin were applied continuously for 24-30 h. Following treatment, all cell processing, sampling and data acquisition steps were accomplished in the same 96-well plate. Data acquisition occurred in a walk-away mode via the use of a high throughput sampling device. The resulting flow cytometric MN values were evaluated with a statistical model that indicated non-linear relationships describe the data better than linear fits. The one exception was bleomycin, where MN induction was consistently best described by a linear dose-response relationship. Collectively, these results suggest that flow cytometry represents a practical and efficient approach for thoroughly examining the dose-response relationship, and clearly benefits studies that seek to characterize no observable genotoxic effect levels, lowest observable genotoxic effect levels, and/or benchmark doses.
Bryce
Steven M
SM
Litron Laboratories, Rochester, NY 14623, United States.
Avlasevich
Svetlana L
SL
Bemis
Jeffrey C
JC
Phonethepswath
Souk
S
Dertinger
Stephen D
SD
D002460:Cell Line; D004249:DNA Damage; D004305:Dose-Response Relationship, Drug; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D015162:Micronucleus Tests / Q000379:methods*; D009153:Mutagens / Q000008:administration & dosage* / Q000633:toxicity
D009153:Mutagens
Environ Mol Mutagen. 2011 May;52(4):280-6
20872831
Mutat Res. 2009 Aug;678(1):30-7
19559100
Mutat Res. 2009 Aug;678(2):95-100
19467345
Cytometry. 1984 Jan;5(1):20-5
6697820
Methods Cell Biol. 1994;42 Pt B:149-58
7533237
Biometrics. 1987 Sep;43(3):511-23
3663815
Environ Mol Mutagen. 2006 Jan;47(1):56-66
16180205
Toxicol Lett. 2009 Nov 12;190(3):317-29
19443141
Mutat Res. 2000 Jan 3;464(1):3-11
10633172
Mutat Res. 2009 Aug;678(2):101-7
19376265
Mutat Res. 2009 Aug;678(2):138-47
19616119
Environ Mol Mutagen. 2010 May;51(4):278-84
19950395
Mutat Res. 2000 Jan 3;464(1):35-40
10633175
Environ Mol Mutagen. 1995;26(4):292-304
8575418
Mutat Res. 2009 Aug;678(2):118-22
19477296
Cancer Res. 2007 Apr 15;67(8):3904-11
17440105
Mutagenesis. 1994 Nov;9(6):503-4
7854140
Mutagenesis. 2006 Jan;21(1):15-20
16364928
Regul Toxicol Pharmacol. 2006 Apr;44(3):198-211
16412543
Mutat Res. 1998 Feb;410(1):3-79
9587424
Toxicol Lett. 2009 Nov 12;190(3):286-97
19446969
Mutat Res. 2007 Jun 15;630(1-2):78-91
17434794
J Nat Prod. 2000 Jan;63(1):158-68
10650103
Mutat Res. 1983 Dec;123(3):281-341
6646151